No phaseCompleted
Next-Generation Synbiotic in Individuals With Overweight or Obesity
Supplementation With a Next-Generation Synbiotic in Individuals With Overweight or Obesity: A Triple-Blinded Randomized Controlled Clinical Trial
- Sponsor
- Texas Christian University (Academic or other)
- Enrolment
- 75 enrolled
- Conditions
- Overweight and Obesity
- Interventions
- Synbiotic Group; Placebo Group
- Ages
- adults
- Registry
- NCT06213480
Full record on ClinicalTrials.gov
From the registry
This study plans to evaluate the effect of consuming a symbiotic (probiotic + prebiotic) for 3 months on body weight, body composition, glucose sensitivity, and psychological parameters, as well as on gut and blood microbial composition. Synbiotic consumption is preceded by a 3-day antibiotic course to help ensure the opening of new niches (houses) for the upcoming beneficial bacteria.
Primary outcomes
- Total Body Fat Mass through DXA (percentage)
- Total Body Fat Mass through BodPod (percentage)
- Fat Mass to Height (kg/m2)
- Fat Mass (kg)
History
Last registry update
Primary completion
Started
Registered